GSK plc
GSK
#233
Rank
HK$790.16 B
Marketcap
HK$394.53
Share price
0.56%
Change (1 day)
26.67%
Change (1 year)

EPS for GSK plc (GSK)

EPS in 2026 (TTM): HK$30.37

According to GSK plc's latest financial reports the company's current EPS (TTM) is HK$30.49. In 2025 the company made an earnings per share (EPS) of HK$29.56 an increase over its 2024 EPS that were of HK$12.51.

EPS history for GSK plc from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$30.372.75%
2025HK$29.56136.36%
2024HK$12.51-47.35%
2023HK$23.76-64.2%
2022HK$66.36182.29%
2021HK$23.51-18.07%
2020HK$28.6922.34%
2019HK$23.4523.9%
2018HK$18.93140.61%
2017HK$7.8764.45%
2016HK$4.78-90.61%
2015HK$50.93178.12%
2014HK$18.31-48.11%
2013HK$35.2922.68%
2012HK$28.76-11.31%
2011HK$32.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$55.07 80.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.28-66.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$20.08-34.14%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$28.05-8.01%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$54.52 78.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$10.75-64.75%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
-HK$2.51-108.23%๐Ÿ‡บ๐Ÿ‡ธ USA